Table 1 Demographic and disease characteristics of patients who underwent full baseline assessment
|  |  | All subjects (N = 15) |  | |
|---|---|---|---|---|
|  |  | Completed (N = 10) | Withdrawn (N = 5) |  |
| Â | Mean (SD) | Â | Â | P |
Age yrs | 67.9 (9.4) | 67.6 (10.9) | 68.4 (6.3) | 0.88 |
Body mass index kg/m 2 | 23.1 (4.6) | 23.7(4.9) | 22.1(4.2) | 0.52 |
| Â | N (%) | Â | Â | Â |
Sex | ||||
 M | 9 (60) | 4 (40) | 5 (100) |  |
 F | 6 (40) | 6 (60) | 0 (0) | 0.04 |
PS | ||||
 1 | 2 (13) | 2 (20) | 0 (0) |  |
 2 | 6 (40) | 4 (40) | 2 (40) |  |
 3 | 7 (47) | 4 (40) | 3 (60) | 0.79 |
Diagnosis | ||||
 Lung cancer | 4 (27) | 3 (30) | 1 (20) |  |
 GI cancer | 6 (40) | 2 (20) | 4 (80) |  |
 Other | 5 (33) | 5 (50) | 0 (0) | NA |
Cancer stage | ||||
 III | 1 (7) | 1 (10) | 0 (0) |  |
 IV | 11 (73) | 6 (60) | 5 (100) |  |
 NA | 3 (20) | 3 (30) | 0 (0) | NA |
Chemotherapy | ||||
 Y | 10 (67) | 6 (60) | 4 (80) |  |
 N | 5 (33) | 4 (40) | 1 (20) | 0.60 |
Recent steroid use | ||||
 Y | 6 (40) | 4 (40) | 2 (40) |  |
 N | 9 (60) | 6 (60) | 3 (60) | 1.00 |